Q4 2024 Tenet Healthcare Corp Earnings Call Transcript
Key Points
- Tenet Healthcare Corp (THC) reported strong financial performance in 2024, with net operating revenues of $20.7 billion and consolidated adjusted EBITDA of $4 billion, representing a 13% growth over 2023.
- The company achieved a full-year adjusted EBITDA margin of 19.3%, improving over 200 basis points from the prior year.
- USPI, a segment of THC, generated $1.81 billion in adjusted EBITDA, marking a 17% growth over 2023, with same-facility revenues growing 7.8%.
- THC successfully executed portfolio transactions, including the sale of 14 hospitals, generating $5 billion in gross proceeds and enabling significant balance sheet deleveraging.
- The company returned capital to shareholders by repurchasing approximately 14% of its outstanding shares for $1.12 billion since the fourth quarter of 2022.
- Despite strong performance, THC faces potential regulatory changes that could impact its operations, particularly in the hospital segment.
- The company reported a slight increase in supply costs as a percentage of revenue, attributed to its push towards higher acuity services.
- THC's guidance for 2025 reflects a more normalized growth rate, with projected adjusted EBITDA growth of 7% at the midpoint, which is lower than the 13% growth achieved in 2024.
- The company anticipates a reduction in adjusted EBITDA due to the divestiture of facilities and non-recurring supplemental Medicaid payments.
- THC's hospital segment faces challenges from potential changes in Medicaid policies and health insurance exchanges, which could impact revenue and profitability.
Good morning. Welcome to Tenet Healthcare's fourth-quarter 2024 earnings conference call. (Operator Instructions)
I'll now turn the call over to your host, Mr. Will McDowell, Vice President of Investor Relations. Mr. McDowell, you may begin.
Good morning, everyone, and thank you for joining today's call. I am Will McDowell, Vice President of Investor Relations. We're pleased to have you join us for a discussion of Tenet's fourth-quarter 2024 results as well as a discussion of our financial outlook. Tenet senior management participating in today's call will be Dr. Saum Sutaria, Chairman and Chief Executive Officer; and Sun Park, Executive Vice President and Chief Financial Officer.
Our webcast this morning includes a slide presentation, which has been posted to the Investor Relations section of our website, tenethealth.com. Listeners to this call are advised that certain statements made during our discussion today are forward-looking and represent management's
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
